In this study, we address possible differences in polyplex activities against therapeutically relevant mRNA in solid breast tumors by directly comparing the activities of Chol-siRNA polyplexes and Chol-DsiRNA polyplexes targeting STAT3 expression in primary murine 4T1 breast tumors after IV administration. This evidence concerns the gene STAT3 and breast neoplasm.